Delivery Order SPE2DB25D7068-SPE2DB25FTWXL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) under a firm fixed-price contract with a ceiling value of $4,174.60. This non-set-aside competitive award is a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $2,239.56 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count). This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 30, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified vendors. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $6,160.10 to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg, a combination medication used to treat type 2 diabetes. This firm fixed-price delivery order, awarded on September 4, 2025, represents a non-competitive set-aside award and is expected to be completed by September 5, 2025. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and...
- The Defense Logistics Agency awarded a delivery order valued at $1,448.64 to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg on April 21, 2025, with an ultimate completion date of April 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,610.07 to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 17, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count) with a contract ceiling value of $4,393.68. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion on July 23, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a $2,408.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg, a combination medication used to treat type 2 diabetes. The contract, awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a non-competitive delivery order executed without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and...
- The Defense Logistics Agency awarded a $3,095.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Janumet 50-1,000 mg, a combination diabetes medication. The contract, which was not set aside and competitively awarded, was executed on September 17, 2025, with an ultimate completion date of September 18, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply delivery supporting...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Janumet 50-1,000 mg tablets in quantities of 1,000 units, with a ceiling value of $2,012.06. This is a firm fixed price delivery order with an ultimate completion date of August 12, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 27, 2025, for the supply of Janumet 50-1,000 mg tablets (60-count units) with a ceiling value of $2,044.98. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion by September 29, 2025, and performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- SPE2DB25D7068Indefinite Delivery Contract
- SPE2DB25D7068-SPE2DB25FTWXLDelivery Order
The Defense Logistics Agency issued a delivery order valued at $3,336.76 to AmerisourceBergen Drug Corp for 180 tablets of Janumet 50-1,000 mg on June 2, 2025, with an ultimate completion date of June 3, 2025. This competitively awarded, firm fixed-price delivery order was placed under no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. Janumet is a combination medication used to treat type 2 diabetes, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical products supplied to federal healthcare systems. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications and medical supplies to military healthcare programs and related federal health systems, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's consistent receipt of competitively awarded contracts across multiple therapeutic domains demonstrates its established capability to meet federal pharmaceutical procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 6/2/25 |